ENTITY
AstraZeneca PLC

AstraZeneca PLC (AZN LN)

130
Analysis
Health CareUnited Kingdom
AstraZeneca PLC operates as a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas, including gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia, and infection.
more
Refresh
09 Jun 2021 16:01

Airport of Thailand (AOT): Phuket Sandbox

The Phuket reopening sandbox will be a proof of concept of whether 1) Thailand's health infrastructure is ready to accept foreign tourists and 2)...

Logo
254 Views
Share
04 Jun 2021 02:33

Betta Pharmaceuticals IPO Initiation: One Step Forward, One Step Back

Betta is pre-marketing an H Share listing to raise $800 million, according to press reports. Overall, we think that Betta faces several challenges...

Logo
214 Views
Share
12 Apr 2021 10:27

Airport of Thailand (AOT): 3rd Wave Is a Charm

The sell off AOT soon due to worsening conditions in the third wave of the COVID-19 outbreak.Investors should take advantage of the sell-off in...

Logo
242 Views
Share
bullishPfizer
12 Apr 2021 00:00Exchange-sponsored

SGX Asia Currencies and Commodities Insights

By Macro Hive   SGX Asia Currencies Insights CNH has traded well against most currencies, and flows remain strong. Therefore, recent USD/CNH...

Share
bullishSK Bioscience
08 Mar 2021 22:50

Trading Strategy of SK Bioscience IPO Post Pricing

The IPO price of SK Bioscience was confirmed at 65,000 won per share, which is at the top of the IPO price range. The total demand ratio of the SK...

Logo
296 Views
Share
x